← 返回专利悬崖列表
CAS 289703-22-6
Benzoic acid (3R,7R,12R)-4(S)-(acetyloxy)-1(S),15(S)-dihydroxy-10(S),14,17,17-tetramethyl-11-oxo-9(S),12(R)-bis[(2(S)2,2,2-trichloroacetyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl ester
登记编号：(II)140605-26-a
应用背景（按来源药适应症）
膀胱癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)头颈癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)头颈部鳞状细胞癌多西他赛纳米胶束 (Samyang Biopharmaceuticals)实体瘤多西他赛纳米胶束 (Samyang Biopharmaceuticals)
来源药（使用该中间体的合成路线）
| 品种 | 梯队 | 到期年 |
|---|---|---|
| 多西他赛纳米胶束 (Samyang Biopharmaceuticals)Docetaxel polymeric micelle (Samyang Biopharmaceuticals) | Tier C · 观察 / 贸易 | - |
合成路线中的位置（上下游链）
按路线登记顺序排列，左→右为合成方向；高亮为当前 CAS，其余可点击跳转对应档案。
(2alpha,5beta,7beta,10beta,13alpha)-4-(Acetyloxy)-1,7,10,13-tetrahydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate→Benzoic acid (3R,7R,12R)-4(S)-(acetyloxy)-1(S),15(S)-dihydroxy-10(S),14,17,17-tetramethyl-11-oxo-9(S),12(R)-bis[(2(S)2,2,2-trichloroacetyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl ester→(4S,5R)-4-Phenyl-2-(tribromomethyl)-1,3-oxazolidine-5-carboxylic acid→(2alpha,5beta,7beta,10beta,13alpha)-4-(Acetyloxy)-1-hydroxy-9-oxo-2-[(phenylcarbonyl)oxy]-7,10-bis[(trichloroacetyl)oxy]-5,20-epoxytax-11-en-13-yl (4S,5R)-4-phenyl-2-(tribromomethyl)-1,3-oxazolidine-5-carboxylate→(2alpha,5beta,7beta,10beta,13alpha)-4-(Acetyloxy)-13-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1-hydroxy-9-oxo-7,10-bis[(trichloroacetyl)oxy]-5,20-epoxytax-11-en-2-yl benzoate→Bis(1,1-dimethylethyl) dicarbonoate→(2alpha,5beta,7beta,10beta,13alpha)-4-(Acetyloxy)-13-([(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl]oxy)-1-hydroxy-9-oxo-7,10-bis[(trichloroacetyl)oxy]-5,20-epoxytax-11-en-2-yl benzoate→(2R,3S)-3-Phenylisoserine methyl ester→Tribromoacetaldehyde→Methyl (4S,5R)-4-phenyl-2-(tribromomethyl)-1,3-oxazolidine-5-carboxylate
本站可供应的对应中间体
目录暂未收录该靶点的在售中间体 —— 可直接发起询价，需求会进入撮合池。
本页为中间体 CAS 注册档案：同 CAS 的多条路线登记已合并；后续供应商报价与买方需求以该 CAS 为主键撮合。